SCHEDULE 13D/AFiled Jun 25, 8:00 PM ET
Kymera Therapeutics, Inc. SCHEDULE 13D/A
BIOTECHNOLOGY VALUE FUND L PSummary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.
This filing does not have a generated research summary. You can still open the original filing and its exhibits.